Development of new methods in diagnosis and treatment of tumors by the targeting of chimeric protein
Development of new methods in diagnosis and treatment of tumors by the targeting of chimeric protein
批准号:
08557018
负责人:
MORI Shigeo
金额:
$9.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998
中文摘要
嵌合基因是一种独特的非自然基因,由两种不同的基因融合而成,产生一种新的蛋白质,头部和尾部由两种不同的基因组成。一些这样的嵌合蛋白引起特殊疾病,如软组织肉瘤和恶性淋巴瘤。本研究旨在(1)鉴定新的致病嵌合基因/蛋白;(2)嵌合蛋白的生物学功能;(3)嵌合蛋白在人类疾病诊断和治疗中的应用。(1)新的致病嵌合基因/蛋白的鉴定:从人恶性淋巴瘤中鉴定出20多个嵌合基因,其中部分嵌合基因来源于BCL6基因。其中一些被发现是新的基因。同时,从人脂肪肉瘤组织中鉴定出一种新的TLS/FUS-CHOP嵌合基因。(2)嵌合蛋白的生物学功能:阐明了NPM/ALK嵌合蛋白的部分生物学功能。BCL6基因产物的生物学功能也得到了部分阐明。(3)嵌合蛋白在人类疾病诊断和治疗中的应用:随着新开发的NPM/ALK嵌合蛋白抗体的引入,我们为NPM/ALK嵌合蛋白相关的人类疾病的诊断提供了一种简便、结论性的方法。此外,我们还可以移植20多例携带不同类型嵌合体基因的人类恶性淋巴瘤。该细胞系目前正在研究这些基因在免疫治疗中的靶向作用。
英文摘要
The chimeric gene is a unique non-natural gene made by the fusion of two different genes, causing production of a novel protein with the head and tail parts made of two different genes. Some of such chimeric protein cause specific diseases like soft part sarcoma and malignant lymphomas. This study was aimed (1)to identify new pathogenetic chimeric genes/proteins, (2)Biological function of chimeric proteins, (3)Application of chimeric proteins in the diagnosis and treatment of human diseases.(1) Identification of new pathogenetic chimeric genes/proteins :Over 20 chimeric genes were identified from human malignant lymphomas a part of which was derived from BCL6 gene. Some of them were found to be new genes. Also, a new type of TLS/FUS-CHOP chimeric gene was identified from human liposarcoma tissues.(2) Biological function of chimeric proteins :A part of the biological functions of NPM/ALK chimeric protein was clarified. Also, the biological function of BCL6 gene product was partly clarified.(3) Application of chimeric proteins in the diagnosis and treatment of human diseases :With the introduction of newly developed antibody to NPM/ALK chimeric protein, we invested an easy and conclusive diagnostic method for the NPM/ALK chimera-related human diseases. Also, we could transfer over 20 cases of human malignant lymphomas bearing different types of chimera genes. This cell line is now under study for the targeting of these genes in immunotherapy.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yee HT: "Molecular characterization of the t (2 ; 5) (p23 ; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease." Blood. 87. 1081-88 (1996)
Yee HT:“间变性大细胞淋巴瘤 (Ki-1) 和霍奇金病中 t (2 ; 5) (p23 ; q35) 易位的分子特征。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aizawa S: "Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation." J Biol Chem. 272(4). 2042-5 (1997)
Aizawa S:“肿瘤坏死因子受体相关因子 (TRAF) 5 和 TRAF2 参与 CD30 介导的 NFkappaB 激活。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aizawa S: "Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene." Gene. 182(1-2). 155-62 (1996)
Aizawa S:“大鼠 CD30 同源物 cDNA 的克隆和表征以及基因组基因的染色体分配。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujimoto J.Shiota M.Iwahara T.Seki N.Satoh H.Mori S.Yamamoto T: "Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t (2 ; 5)." Proc Natl Acad Sci USA. 93 (9). 41
Fujimoto J.Shiota M.Iwahara T.Seki N.Satoh H.Mori S.Yamamoto T:“p80 转化活性的表征,p80 是具有染色体易位的 Ki-1 淋巴瘤细胞系中的一种过度磷酸化蛋白 t (2 ; 5)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Aizawa S.Nakano H.Ishida T.Horie R.Nagai M.Ito K.Yagita H.Okumura K.Inoue J.Watanabe T: "Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation." J Biol Chem. 272 (4). 2042-2045 (1997)
Aizawa S.Nakano H.Ishida T.Horie R.Nagai M.Ito K.Yagita H.Okumura K.Inoue J.Watanabe T:“肿瘤坏死因子受体相关因子 (TRAF) 5 和 TRAF2 参与 CD30 介导的
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 43 条
Exploration of new magnetic materials by controlling nanostructures
-
批准号:23656404
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2011
-
负责人:MORI Shigeo
-
依托单位:
Magnetoelecric relaxors
-
批准号:20340078
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2008
-
负责人:MORI Shigeo
-
依托单位:
Construction of Database on Iranian Worship and Belief and Applied Research of Theories of Persian Literature in Expanded Form
-
批准号:19320050
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2007
-
负责人:MORI Shigeo
-
依托单位:
Correlation Phenomena among electric, magnetic and mulitiple dipoles in ferroelectric oxides
-
批准号:16340094
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.55万
-
财政年份:2004
-
负责人:MORI Shigeo
-
依托单位:
Construction of datahaceonworship and bolief and applied research of theories of Persian literature
-
批准号:16320044
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.23万
-
财政年份:2004
-
负责人:MORI Shigeo
-
依托单位:
Subtyping of diffuse large B cell lymphomas by molecules highly expressed on germinal center B cells.
-
批准号:13470042
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.87万
-
财政年份:2001
-
负责人:MORI Shigeo
-
依托单位:
Remodeling of the classification of malignant lymphomas occurring among Japanese based on molecular abnormality
-
批准号:08307003
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$20.48万
-
财政年份:1996
-
负责人:MORI Shigeo
-
依托单位:
The pathology of Ki-1 lymphoma
-
批准号:07457048
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:1995
-
负责人:MORI Shigeo
-
依托单位:
Use of receptor-type oncogene c-ergB-2 for the diagnosis and treatment of human cancers
-
批准号:04557019
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$10.37万
-
财政年份:1992
-
负责人:MORI Shigeo
-
依托单位:
Analysis of dorsal light tilt reaction and cerebellar activities in carp during aircraft parabolic-flight weightlessness
-
批准号:60480119
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.16万
-
财政年份:1985
-
负责人:MORI Shigeo
-
依托单位:
海外基金